These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 32898332)

  • 21. miR-581-Related Single Nucleotide Polymorphism, rs2641726, Located in MUC4 Gene, is Associated with Gastric Cancer Incidence.
    Nabatchian F; Rahimi Naiini M; Moradi A; Tabatabaeian H; Hoghoughi N; Azadeh M; Ghaedi K
    Indian J Clin Biochem; 2019 Jul; 34(3):347-351. PubMed ID: 31391727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Invasive micropapillary carcinoma of the breast overexpresses MUC4 and is associated with poor outcome to adjuvant trastuzumab in HER2-positive breast cancer.
    Mercogliano MF; Inurrigarro G; De Martino M; Venturutti L; Rivas MA; Cordo-Russo R; Proietti CJ; Fernández EA; Frahm I; Barchuk S; Allemand DH; Figurelli S; Deza EG; Ares S; Gercovich FG; Cortese E; Amasino M; Guzmán P; Roa JC; Elizalde PV; Schillaci R
    BMC Cancer; 2017 Dec; 17(1):895. PubMed ID: 29281999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functions of MUC16 in corneal epithelial cells.
    Blalock TD; Spurr-Michaud SJ; Tisdale AS; Heimer SR; Gilmore MS; Ramesh V; Gipson IK
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4509-18. PubMed ID: 17898272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of membrane-associated mucins in limbal stem cell deficiency and after transplantation of cultivated limbal epithelium.
    Pauklin M; Kakkassery V; Steuhl KP; Meller D
    Curr Eye Res; 2009 Mar; 34(3):221-30. PubMed ID: 19274530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The clinical utility of CA125/MUC16 in pancreatic cancer: A consensus of diagnostic, prognostic and predictive updates by the Chinese Study Group for Pancreatic Cancer (CSPAC).
    Liu L; Xiang J; Chen R; Fu D; Hong D; Hao J; Li Y; Li J; Li S; Mou Y; Mai G; Ni Q; Peng L; Qin R; Qian H; Shao C; Sun B; Sun Y; Tao M; Tian B; Wang H; Wang J; Wang L; Wang W; Wang W; Zhang J; Zhao G; Zhou J; Yu X;
    Int J Oncol; 2016 Mar; 48(3):900-7. PubMed ID: 26718269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MUC4 mucin potentiates pancreatic tumor cell proliferation, survival, and invasive properties and interferes with its interaction to extracellular matrix proteins.
    Chaturvedi P; Singh AP; Moniaux N; Senapati S; Chakraborty S; Meza JL; Batra SK
    Mol Cancer Res; 2007 Apr; 5(4):309-20. PubMed ID: 17406026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic Mutation and Exosome Signature of Human Papilloma Virus Associated Oropharyngeal Cancer.
    Kannan A; Hertweck KL; Philley JV; Wells RB; Dasgupta S
    Sci Rep; 2017 Apr; 7():46102. PubMed ID: 28383029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Predictive Value of Tumor Mutation Burden in Immunotherapy for Lung Cancer].
    Sa H; Ma K; Gao Y; Wang D
    Zhongguo Fei Ai Za Zhi; 2019 Jun; 22(6):380-384. PubMed ID: 31196372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Mucin 16 bispecific T cell-engaging antibody for the treatment of ovarian cancer.
    Crawford A; Haber L; Kelly MP; Vazzana K; Canova L; Ram P; Pawashe A; Finney J; Jalal S; Chiu D; Colleton CA; Garnova E; Makonnen S; Hickey C; Krueger P; DelFino F; Potocky T; Kuhnert J; Godin S; Retter MW; Duramad P; MacDonald D; Olson WC; Fairhurst J; Huang T; Martin J; Lin JC; Smith E; Thurston G; Kirshner JR
    Sci Transl Med; 2019 Jun; 11(497):. PubMed ID: 31217340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Different levels of sialyl-Tn antigen expressed on MUC16 in patients with endometriosis and ovarian cancer.
    Akita K; Yoshida S; Ikehara Y; Shirakawa S; Toda M; Inoue M; Kitawaki J; Nakanishi H; Narimatsu H; Nakada H
    Int J Gynecol Cancer; 2012 May; 22(4):531-8. PubMed ID: 22367369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of tumor burden measurement using the number of tumors in non-surgical patients with non-small cell lung cancer.
    Zhang H; Wroblewski K; Pu Y
    Acta Radiol; 2012 Jun; 53(5):561-8. PubMed ID: 22661603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlate tumor mutation burden with immune signatures in human cancers.
    Wang X; Li M
    BMC Immunol; 2019 Jan; 20(1):4. PubMed ID: 30634925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The mucin MUC4 is a transcriptional and post-transcriptional target of K-ras oncogene in pancreatic cancer. Implication of MAPK/AP-1, NF-κB and RalB signaling pathways.
    Vasseur R; Skrypek N; Duchêne B; Renaud F; Martínez-Maqueda D; Vincent A; Porchet N; Van Seuningen I; Jonckheere N
    Biochim Biophys Acta; 2015 Dec; 1849(12):1375-84. PubMed ID: 26477488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systematical Analysis of the Cancer Genome Atlas Database Reveals
    Dai W; Liu J; Liu B; Li Q; Sang Q; Li YY
    Front Mol Biosci; 2020; 7():19. PubMed ID: 32175327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of the membrane mucins MUC4 and MUC15, potential markers of malignancy and prognosis, in papillary thyroid carcinoma.
    Nam KH; Noh TW; Chung SH; Lee SH; Lee MK; Hong SW; Chung WY; Lee EJ; Park CS
    Thyroid; 2011 Jul; 21(7):745-50. PubMed ID: 21615302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integrated characterisation of cancer genes identifies key molecular biomarkers in stomach adenocarcinoma.
    Wang H; Shen L; Li Y; Lv J
    J Clin Pathol; 2020 Sep; 73(9):579-586. PubMed ID: 32034058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aberrant methylation of MUC1 and MUC4 promoters are potential prognostic biomarkers for pancreatic ductal adenocarcinomas.
    Yokoyama S; Higashi M; Kitamoto S; Oeldorf M; Knippschild U; Kornmann M; Maemura K; Kurahara H; Wiest E; Hamada T; Kitazono I; Goto Y; Tasaki T; Hiraki T; Hatanaka K; Mataki Y; Taguchi H; Hashimoto S; Batra SK; Tanimoto A; Yonezawa S; Hollingsworth MA
    Oncotarget; 2016 Jul; 7(27):42553-42565. PubMed ID: 27283771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutation patterns in genes encoding interferon signaling and antigen presentation: A pan-cancer survey with implications for the use of immune checkpoint inhibitors.
    Budczies J; Bockmayr M; Klauschen F; Endris V; Fröhling S; Schirmacher P; Denkert C; Stenzinger A
    Genes Chromosomes Cancer; 2017 Aug; 56(8):651-659. PubMed ID: 28466543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MUC4 mucin- a therapeutic target for pancreatic ductal adenocarcinoma.
    Gautam SK; Kumar S; Cannon A; Hall B; Bhatia R; Nasser MW; Mahapatra S; Batra SK; Jain M
    Expert Opin Ther Targets; 2017 Jul; 21(7):657-669. PubMed ID: 28460571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathobiological implications of MUC4 in non-small-cell lung cancer.
    Majhi PD; Lakshmanan I; Ponnusamy MP; Jain M; Das S; Kaur S; Shimizu ST; West WW; Johansson SL; Smith LM; Yu F; Rolle CE; Sharma P; Carey GB; Batra SK; Ganti AK
    J Thorac Oncol; 2013 Apr; 8(4):398-407. PubMed ID: 23370366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.